WYZGA MICHAEL S
SEC insider (Form 3/4/5 filer). CIK 0001201256. Director at Tvardi Therapeutics, Inc. (TVRD) and 2 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in SUGAR LAND, TX.
Companies WYZGA MICHAEL S has filed insider reports for
- Tvardi Therapeutics, Inc. (TVRD): Director
- Mereo BioPharma Group plc (MREO): Director
- X4 Pharmaceuticals, Inc (XFOR): Director
WYZGA MICHAEL S
CIK: 0001201256
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 9, 2026TVRD
Tvardi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
6K shares- - Feb 26, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
66K shares- - Jan 1, 2026XFOR
X4 Pharmaceuticals, Inc
AwardDirectStock Option (right to buy)
110K shares- - Jun 9, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirect1.5K shares- - Apr 17, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
12K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
18.4K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
AwardDirectDeferred Restricted Stock Units
30.5K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
55K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  TVRD Tvardi Therapeutics, Inc. | Award Stock Option (right to buy) | 6,000 | - | - | Direct |
| Feb 26, 2026 |  MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 66,000 | - | - | Direct |
| Jan 1, 2026 |  XFOR X4 Pharmaceuticals, Inc | Award Stock Option (right to buy) | 110,000 | - | - | Direct |
| Jun 9, 2025 | XFOR X4 Pharmaceuticals, Inc | Award | 1,500 | - | - | Direct |
| Apr 17, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Stock Option (right to buy) | 12,000 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Stock Option (right to buy) | 18,441 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award Deferred Restricted Stock Units | 30,487 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 55,000 | - | - | Direct |
1-8 of 8 transactions